Nabriva receives FDA approval for novel antibiotics
The drug, which will be offered both for intravenous and for oral administration, blocks the peptidyl transferase domain of the ribosome. The drug...
AMR: ENABLE selects Mutabilis candidate
Efficacy of beta-lactam antibiotics, which represent 65% of the antibiotics sold throughout the world, is increasingly challenged in Gram-negative...
Novo Holdings puts $72m in Lanzatech
The Series E financing was Novo Holdings’ fourth investment within the growth equity area this year. Growth equity investments enable Novo...
New risk factor for autism and epilepsy identified
The KCC2 K+Cl– co-transporter is critical for the health and maturity of neurons, as it helps to maintain a low concentration of chloride ions in...
Preclinical antibody stops rheumatoid arthritis
Autoimmune diseases affect almost 5% of the population, but many patients cannot tolerate the long-term use of immunosuppressive therapies....
ADC Therapeutics and Freenome enter biomarker collaboration
Under the biomarker development collaboration, ADC Therapeutics SA (Lausanne) will employ Freenome's multiomics platform to identify biomarkers that...
New malaria lead kills 99.9% of pathogens
The researchers built on the fact, that Plasmodium is highly dependent on external supply and metabolisation of vitamin B 5 (pantothenamide). They...